Myositis-specific autoantibodies are specific for myositis compared to genetic muscle disease
Citation Manager Formats
Make Comment
See Comments

Abstract
Objective: To determine the specificity of myositis-specific autoantibodies (MSAs) for autoimmune myopathy compared with inherited muscle diseases.
Methods: Serum samples from 47 patients with genetically confirmed inherited muscle diseases were screened for the most common MSAs, including those recognizing TIF1γ, NXP2, Mi2, MDA5, Jo1, SRP, and HMGCR. We compared these results with the findings in a cohort of patients with dermatomyositis (DM) previously screened for anti-TIF1γ, -NXP2, -Mi2, -MDA5, and -Jo1.
Results: Overall, the presence of anti-TIF1γ, -NXP2, -Mi2, -MDA5, or -Jo1 was 96% specific and 67% sensitive for DM compared to patients with genetic muscle diseases. No patients with inherited muscle disease had anti-SRP or anti-HMGCR autoantibodies. Only 2 patients with genetic muscle disease had a MSA. One patient with anti-Mi2 autoantibodies had both genetically confirmed facioscapulohumeral dystrophy and dermatomyositis based on a typical skin rash and partial response to immunosuppressive medications. A second patient with anti-Jo-1 autoantibodies had both genetically defined limb-girdle muscular dystrophy type 2A (i.e., calpainopathy) and a systemic autoimmune process based on biopsy-confirmed lupus nephritis, sicca symptoms, and anti-Ro52 autoantibodies.
Conclusions: The MSAs tested for in this study are highly specific for autoimmune muscle disease and are rarely, if ever, found in patients who only have genetic muscle disease. In patients with genetic muscle disease, the presence of a MSA should suggest the possibility of a coexisting autoimmune process.
GLOSSARY
- DM=
- dermatomyositis;
- FSHD=
- facioscapulohumeral dystrophy;
- HMGCR=
- HMG-CoA reductase;
- IMNM=
- immune-mediated necrotizing myopathy;
- IVTT=
- in vitro transcription and translation;
- LGMD=
- limb-girdle muscular dystrophies;
- MSA=
- myositis-specific autoantibody;
- PM=
- polymyositis
Footnotes
Funding information and disclosures are provided at the end of the article. Go to Neurology.org/nn for full disclosure forms. The Article Processing Charge was paid by the authors.
- Received June 26, 2015.
- Accepted in final form September 16, 2015.
- © 2015 American Academy of Neurology
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND), which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Sevil Yaşar and Dr. Behnam Sabayan
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Article
Identification of distinctive interferon gene signatures in different types of myositisIago Pinal-Fernandez, Maria Casal-Dominguez, Assia Derfoul et al.Neurology, August 21, 2019 -
Article
More prominent muscle involvement in patients with dermatomyositis with anti-Mi2 autoantibodiesIago Pinal-Fernandez, Christopher A. Mecoli, Maria Casal-Dominguez et al.Neurology, October 08, 2019 -
Article
Muscular and extramuscular features of myositis patients with anti-U1-RNP autoantibodiesMaria Casal-Dominguez, Iago Pinal-Fernandez, Andrea M. Corse et al.Neurology, March 01, 2019 -
Article
Muscular and extramuscular clinical features of patients with anti-PM/Scl autoantibodiesRebecca De Lorenzo, Iago Pinal-Fernandez, Wilson Huang et al.Neurology, May 04, 2018